Sponsor Pipeline

Pharmicell Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
4
Recruiting
1
Phase 3
Active Trials by Phase
Phase 3
1
Not specified
4
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04689152 Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in… Alcoholic Cirrhosis Recruiting
Not specified
NCT05093881 Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered… Alcoholic Cirrhosis Recruiting
NCT07400458 Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration Acute Myocardial Infarction Recruiting
NCT07431008 Safety Follow-up Study of Cellgram-ED in Post-Radical Prostatectomy Erectile Dysfunction Erectile Dysfunction Recruiting
NCT05096182 Long-term Follow-up of Patients With Chronic Kidney Disease Who Had Administered… Renal Insufficiency, Chronic Active, Not Recruiting
Get alerts when Pharmicell Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free